Although SMARCB1 is not frequently mutated in melanoma (Figure 2, Table 1), inactivating mutations in SMARCB1 frequently occur in a number of other cancers, especially in pediatric rhabdoid tumors, where there is frequent biallelic SMARCB1 disruption [105,106,107,108]. Here, SMARCB1 is linked to rhabdoid tumor.